AST-120
AST-120 is a pharmaceutical drug with 12 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
6
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
10 of 12 finished
16.7%
2 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
AST-120 in Hemodialysis Patients With Uremic Pruritus
Safety and Efficacy of AST-120 in the Treatment of Pouchitis
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
Clinical Trials (12)
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
AST-120 in Hemodialysis Patients With Uremic Pruritus
Safety and Efficacy of AST-120 in the Treatment of Pouchitis
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
AST-120 Used to Treat Mild Hepatic Encephalopathy
Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
Kremezin Study Against Renal Disease Progression in Korea
Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12